PathKey Shares Rise 44% on Chipforge Deal and CEO Appointment

No Hidden News Behind Share Price Surge

PathKey.AI Ltd (ASX:PKY) has responded to an ASX price query concerning a notable rise in its share price from 4.3 cents on 11 June 2026 to an intraday high of 6.2 cents on 15 June, alongside a surge in trading volume. The company firmly stated it is unaware of any material information not already disclosed to the market that could explain this recent trading activity.

Chipforge Acquisition and CEO Appointment Drive Interest

The share price movement appears tied to PathKey’s earlier announcements, including the binding agreement to acquire Singapore-based Chipforge Pte Ltd disclosed on 29 April and the appointment of Andrew Farnsworth as CEO on 11 May. Farnsworth, a defence and AI veteran, is expected to accelerate the commercialisation of PathKey’s AI platforms. The company highlighted an upcoming shareholder meeting scheduled for 17 June, where investors will vote on resolutions related to securities issued as part of the Chipforge acquisition.

Early-Stage Business Development and AI Sector Interest

While PathKey continues to advance business development and R&D around its TrialKey platform, these discussions remain at an early stage without any price-sensitive commercial arrangements. The company also acknowledged that broader investor enthusiasm for AI-related opportunities, combined with its strong balance sheet and strategic positioning, may be contributing to the recent trading dynamics.

Compliance and Disclosure Assurance

PathKey affirmed full compliance with ASX Listing Rules, particularly continuous disclosure obligations under Listing Rule 3.1. The company’s responses to the ASX query were authorised by its board, reinforcing its commitment to transparency. The ASX had raised the possibility that recent trading might indicate confidential information had leaked or ceased to be confidential, but PathKey’s clear denial of any undisclosed news mitigates that concern.

What Comes Next for PathKey

Investors will be closely watching the outcome of the 17 June shareholder meeting, which could unlock the Chipforge acquisition and potentially reshape PathKey’s growth trajectory. Meanwhile, progress in commercialising TrialKey and any new business developments could provide fresh catalysts. The company’s ability to maintain clear communication amid heightened market interest will remain critical as it navigates these pivotal events.